The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.

Ai, P; Zhang, X; Xie, Z; Liu, G; Liu, X; Pan, S; Wang, H

Ai, P; Zhang, X; Xie, Z; Liu, G; Liu, X; Pan, S; Wang, H.

Afiliación

Ai P; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhang X; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xie Z; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu G; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu X; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pan S; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wang H; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Acta Neurol Scand ; 137(2): 277-282, 2018 Feb.

Article en En | MEDLINE | ID: mdl-29023630

Asunto(s)

Encefalitis Antirreceptor N-Metil-D-Aspartato/líquido cefalorraquídeo; Proteína HMGB1/líquido cefalorraquídeo; Interleucina-6/líquido cefalorraquídeo; Adulto; Estudios Transversales; Ensayo de Inmunoadsorción Enzimática; Femenino; Humanos; Interleucina-17/líquido cefalorraquídeo; Masculino

Palabras clave

anti-NMDAR encephalitis; cerebrospinal fluid; cytokine; high-mobility group box protein 1; inflammation; modified Rankin scale

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Proteína HMGB1 / Encefalitis Antirreceptor N-Metil-D-Aspartato Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Acta Neurol Scand Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google